These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37330048)

  • 1. Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with Hematuria.
    Oh TJ; Lee JY; Seo Y; Woo MA; Lim JS; Na YG; Song KH; Bang BR; Lee JJ; Shin JH; An S
    J Mol Diagn; 2023 Sep; 25(9):646-654. PubMed ID: 37330048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EarlyTect BCD, a Streamlined PENK Methylation Test in Urine DNA, Effectively Detects Bladder Cancer in Patients with Hematuria.
    Bang BR; Zhong J; Oh TJ; Lee JY; Seo Y; Woo MA; Lim JS; Na YG; Song KH; Shin JH; Lee JJ; Im CS; Kim S; Beqaj S; Shirk JD; Ke KW; Vallone J; An S
    J Mol Diagn; 2024 Jul; 26(7):613-623. PubMed ID: 38677548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
    van Kessel KE; Beukers W; Lurkin I; Ziel-van der Made A; van der Keur KA; Boormans JL; Dyrskjøt L; Márquez M; Ørntoft TF; Real FX; Segersten U; Malats N; Malmström PU; Van Criekinge W; Zwarthoff EC
    J Urol; 2017 Mar; 197(3 Pt 1):590-595. PubMed ID: 27746284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy.
    van Kessel KEM; de Jong JJ; Ziel-van der Made ACJ; Roshani H; Haensel SM; Wolterbeek JH; Boevé ER; Oomens EHGM; van Casteren NJ; Krispin M; Boormans JL; Steyerberg EW; van Criekinge W; Zwarthoff EC
    J Urol; 2020 Jul; 204(1):50-57. PubMed ID: 31985322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patients.
    Pharo HD; Jeanmougin M; Ager-Wick E; Vedeld HM; Sørbø AK; Dahl C; Larsen LK; Honne H; Brandt-Winge S; Five MB; Monteiro-Reis S; Henrique R; Jeronimo C; Steven K; Wahlqvist R; Guldberg P; Lind GE
    Clin Epigenetics; 2022 Sep; 14(1):115. PubMed ID: 36115961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer.
    Ruan W; Chen X; Huang M; Wang H; Chen J; Liang Z; Zhang J; Yu Y; Chen S; Xu S; Hu T; Li X; Guo Y; Jiang Z; Chen Z; Huang J; Lin T; Fan JB
    Clin Epigenetics; 2021 Apr; 13(1):91. PubMed ID: 33902700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.
    Oh TJ; Lim E; Bang BR; Lee JJ; Na YG; Shin JH; Lim JS; Song KH; An S
    BMC Cancer; 2022 Nov; 22(1):1195. PubMed ID: 36403035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples.
    Piatti P; Chew YC; Suwoto M; Yamada T; Jara B; Jia XY; Guo W; Ghodoussipour S; Daneshmand S; Ahmadi H; Rice J; Bhasin J; Holloway F; Tsai Y; Chihara Y; Liang G
    Clin Epigenetics; 2021 Apr; 13(1):84. PubMed ID: 33882992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
    Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
    Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
    Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
    BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
    Fantony JJ; Abern MR; Gopalakrishna A; Owusu R; Jack Tay K; Lance RS; Inman BA
    Urol Oncol; 2015 Sep; 33(9):387.e1-6. PubMed ID: 26027762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of urothelial carcinoma, upper tract urothelial carcinoma, bladder carcinoma, and urothelial carcinoma with gross hematuria using selected urine-DNA methylation biomarkers: A prospective, single-center study.
    Guo RQ; Xiong GY; Yang KW; Zhang L; He SM; Gong YQ; He Q; Li XY; Wang ZC; Bao ZQ; Li XS; Zhang K; Zhou LQ
    Urol Oncol; 2018 Jul; 36(7):342.e15-342.e23. PubMed ID: 29706459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Validation of the Proenkephalin (
    Han H; Oh TJ; Heo JE; Lee J; Jang WS; Lee SH; Ham WS; Hwang J; An S; Choi YD
    Eur Urol Open Sci; 2024 Apr; 62():99-106. PubMed ID: 38496823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
    Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR
    Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine cell-based DNA methylation classifier for monitoring bladder cancer.
    van der Heijden AG; Mengual L; Ingelmo-Torres M; Lozano JJ; van Rijt-van de Westerlo CCM; Baixauli M; Geavlete B; Moldoveanud C; Ene C; Dinney CP; Czerniak B; Schalken JA; Kiemeney LALM; Ribal MJ; Witjes JA; Alcaraz A
    Clin Epigenetics; 2018; 10():71. PubMed ID: 29854012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder Cancer detection by urinary methylation markers GHSR/MAL: a validation study.
    Beijert IJ; van den Burgt Y; Hentschel AE; Bosschieter J; Kauer PC; Lissenberg-Witte BI; van Moorselaar RJA; Nieuwenhuijzen JA; Steenbergen RDM
    World J Urol; 2024 Oct; 42(1):578. PubMed ID: 39412544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.
    Chung W; Bondaruk J; Jelinek J; Lotan Y; Liang S; Czerniak B; Issa JP
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1483-91. PubMed ID: 21586619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
    Piao XM; Jeong P; Kim YH; Byun YJ; Xu Y; Kang HW; Ha YS; Kim WT; Lee JY; Woo SH; Kwon TG; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
    Int J Cancer; 2019 Jan; 144(2):380-388. PubMed ID: 30183088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Analysis of
    Lotan Y; Raman JD; Konety B; Daneshmand S; Schroeck F; Shariat SF; Black P; de Lange M; Asroff S; Goldfischer E; Efros M; Chong KT; Huang E; Chua HL; Wu QH; Yeow S; Lau W; Yong J; Eng M
    J Urol; 2023 Apr; 209(4):762-772. PubMed ID: 36583640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.